The Effect of Starting Blood Glucose Levels on Serum Electrolyte Concentrations during and after Exercise in Type 1 Diabetes

Int J Environ Res Public Health. 2023 Jan 24;20(3):2109. doi: 10.3390/ijerph20032109.

Abstract

Fear of hypoglycemia is a major exercise barrier for people with type 1 diabetes (PWT1D). Consequently, although guidelines recommend starting exercise with blood glucose (BG) concentration at 7-10 mmol/L, PWT1D often start higher, potentially affecting hydration and serum electrolyte concentrations. To test this, we examined serum and urine electrolyte concentrations during aerobic exercise (cycling 45 min at 60%VO2peak) in 12 PWT1D (10F/2M, mean ± SEM: age 29 ± 2.3 years, VO2peak 37.9 ± 2.2 mL·kg-1·min-1) with starting BG levels: 8-10 (MOD), and 12-14 (HI) mmol/L. Age, sex, and fitness-matched controls without diabetes (CON) completed one exercise session with BG in the normal physiological range. Serum glucose was significantly higher during exercise and recovery in HI versus MOD (p = 0.0002 and p < 0.0001, respectively) and in MOD versus CON (p < 0.0001). During exercise and recovery, MOD and HI were not significantly different in serum insulin (p = 0.59 and p = 0.63), sodium (p = 0.058 and p = 0.08), potassium (p = 0.17 and p = 0.16), calcium (p = 0.75 and 0.19), and magnesium p = 0.24 and p = 0.09). Our findings suggest that exercise of moderate intensity and duration with higher BG levels may not pose an immediate risk to hydration or serum electrolyte concentrations for PWT1D.

Keywords: blood glucose; electrolytes; exercise; hydration; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose
  • Diabetes Mellitus, Type 1*
  • Electrolytes
  • Exercise / physiology
  • Humans
  • Hypoglycemia*
  • Insulin

Substances

  • Blood Glucose
  • Insulin
  • Electrolytes

Grants and funding

J.E.Y. is supported by the Heart and Stroke Foundation Alberta New Investigator Award. This project was funded by a pilot project grant from the Alberta Diabetes Institute. In-kind support was provided by LifeScan Canada and Abbott Nutrition Canada. Zeinab Momeni is supported by the Alberta Women’s Health Foundation through the Women and Children’s Health Research Institute.